Program:
The Nucleic Acid-Based Technologies program will address a variety of emerging technologies as well as novel strategies, such as in situ amplification. Current challenges, such as more precise quantitation, simultaneous detection of numerous and varied mutations, increased performance, automation and high throughput will be discussed. Insight into the clinical utility and application of these technologies for patient management, prognostic factors and therapy monitoring in the areas of cancer, genetics and viral detection and quantification will be highlighted. This program provides a convenient means of learning more about the latest technical advances, novel emerging technologies and exploring the breadth of potential in the clinical setting. Directors and heads of clinical and reference labs, hospitals, product managers, researchers and business development managers as well as end users will find this meeting invaluable.
Registration :
Cambridge Healthtech Institute
1037 Chestnut Street
Newton Upper Falls, MA 02164
tel: 617-630-1300
fax: 617-630-1325
Deadline for Abstracts: 2/96
Email for Requests and Registration: chi@healthtech.com